Stem definition | Drug id | CAS RN |
---|---|---|
589 | 56-75-7 |
Dose | Unit | Route |
---|---|---|
3 | g | O |
3 | g | P |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 1 | Benet LZ, Broccatelli F, Oprea TI |
S (Water solubility) | 2.50 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 5 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 309.47 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 82 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Vd (Volume of distribution) | 0.94 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 2.40 mL/min/kg | Lombardo F, Berellini G, Obach RS |
fu (Fraction unbound in plasma) | 0.34 % | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 4.60 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
Dec. 8, 1950 | FDA | PARKEDALE |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Keratopathy | 100.83 | 27.13 | 16 | 1639 | 290 | 46684117 |
Cholestasis of pregnancy | 62.33 | 27.13 | 13 | 1642 | 1111 | 46683296 |
Parophthalmia | 59.97 | 27.13 | 10 | 1645 | 249 | 46684158 |
Toxic anterior segment syndrome | 54.01 | 27.13 | 13 | 1642 | 2124 | 46682283 |
Intraocular pressure increased | 53.53 | 27.13 | 16 | 1639 | 5941 | 46678466 |
Conjunctival oedema | 45.70 | 27.13 | 9 | 1646 | 576 | 46683831 |
Exophthalmos | 45.14 | 27.13 | 10 | 1645 | 1135 | 46683272 |
Genital rash | 41.19 | 27.13 | 8 | 1647 | 476 | 46683931 |
Eye swelling | 40.93 | 27.13 | 18 | 1637 | 20085 | 46664322 |
Right ventricular hypertrophy | 38.54 | 27.13 | 8 | 1647 | 667 | 46683740 |
Eye pain | 32.40 | 27.13 | 17 | 1638 | 27923 | 46656484 |
Lip swelling | 28.16 | 27.13 | 15 | 1640 | 25380 | 46659027 |
Pulmonary infarction | 27.61 | 27.13 | 8 | 1647 | 2663 | 46681744 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Keratopathy | 56.80 | 35.29 | 9 | 879 | 195 | 29951395 |
Corneal oedema | 51.20 | 35.29 | 11 | 877 | 1301 | 29950289 |
Source | Code | Description |
---|---|---|
ATC | D06AX02 | DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE ANTIBIOTICS FOR TOPICAL USE Other antibiotics for topical use |
ATC | D10AF03 | DERMATOLOGICALS ANTI-ACNE PREPARATIONS ANTI-ACNE PREPARATIONS FOR TOPICAL USE Antiinfectives for treatment of acne |
ATC | G01AA05 | GENITO URINARY SYSTEM AND SEX HORMONES GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS Antibiotics |
ATC | J01BA01 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE AMPHENICOLS Amphenicols |
ATC | S01AA01 | SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFECTIVES Antibiotics |
ATC | S02AA01 | SENSORY ORGANS OTOLOGICALS ANTIINFECTIVES Antiinfectives |
ATC | S03AA08 | SENSORY ORGANS OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS ANTIINFECTIVES Antiinfectives |
FDA EXT | N0000175479 | Amphenicols |
FDA EPC | N0000175480 | Amphenicol-class Antibacterial |
MeSH PA | D000900 | Anti-Bacterial Agents |
MeSH PA | D000890 | Anti-Infective Agents |
MeSH PA | D004791 | Enzyme Inhibitors |
MeSH PA | D011500 | Protein Synthesis Inhibitors |
CHEBI has role | CHEBI:33281 | antibiotics |
CHEBI has role | CHEBI:36047 | antibacterial drugs |
CHEBI has role | CHEBI:48001 | protein synthesis inhibitors |
CHEBI has role | CHEBI:76971 | e.coli metabolites |
CHEBI has role | CHEBI:131604 | mycoplasma genitalium metabolites |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Otitis externa | indication | 3135009 | |
Streptococcal meningitis | indication | 4510004 | DOID:11574 |
Typhoid fever | indication | 4834000 | DOID:13258 |
Disease caused by rickettsiae | indication | 37246009 | |
Paratyphoid fever | indication | 85904008 | DOID:3055 |
Bacterial infection of skin | indication | 128936008 | |
Boutonneuse fever | indication | 186774005 | DOID:14095 |
Meningococcal meningitis | indication | 192644005 | |
Superficial Ocular Infection | indication | ||
H. Influenzae Meningitis | indication | ||
Bacteroides Brain Abscess | indication | ||
Inhalational anthrax | off-label use | 11389007 | |
Exposure keratoconjunctivitis | off-label use | 14366000 | DOID:9461 |
Blepharoconjunctivitis | off-label use | 68659002 | DOID:2456 |
Gastrointestinal anthrax | off-label use | 111798006 | DOID:13386 |
Bacterial conjunctivitis | off-label use | 128350005 | DOID:9700 |
Neuropathic corneal ulcer | off-label use | 231901007 | |
Gas gangrene caused by clostridium perfringens | off-label use | 266093005 | |
Infective blepharitis | off-label use | 312219000 | |
Bacterial keratitis | off-label use | 314557000 | |
Anthrax | off-label use | 409498004 | DOID:7427 |
Mastoidectomy Cavity Infections | off-label use | ||
Paroxysmal nocturnal hemoglobinuria | contraindication | 1963002 | DOID:0060284 |
Hypoplastic anemia | contraindication | 41614006 | |
Optic neuritis | contraindication | 66760008 | DOID:1210 |
Kidney disease | contraindication | 90708001 | DOID:557 |
Anemia due to enzyme deficiency | contraindication | 111577008 | |
Acute intermittent porphyria | contraindication | 234422006 | DOID:3890 |
Disease of liver | contraindication | 235856003 | DOID:409 |
Anemia | contraindication | 271737000 | DOID:2355 |
Thrombocytopenic disorder | contraindication | 302215000 | DOID:1588 |
Peripheral nerve disease | contraindication | 302226006 | |
Aplastic anemia | contraindication | 306058006 | DOID:12449 |
Bone marrow depression | contraindication | 307762000 | |
Breastfeeding (mother) | contraindication | 413712001 | |
Granulocytopenic disorder | contraindication | 417672002 | |
Significant Bleeding | contraindication |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 9.75 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Cytochrome P450 3A4 | Enzyme | IC50 | 4.25 | WOMBAT-PK | |||||
Streptokinase A | Enzyme | EC50 | 6.01 | WOMBAT-PK | |||||
Chloramphenicol acetyltransferase | Enzyme | Kd | 4.89 | WOMBAT-PK | |||||
Probable HTH-type transcriptional regulator TtgR | Unclassified | Kd | 4.88 | WOMBAT-PK |
ID | Source |
---|---|
4018199 | VUID |
N0000146533 | NUI |
D00104 | KEGG_DRUG |
4018199 | VANDF |
4021527 | VANDF |
C0008168 | UMLSCUI |
CHEBI:17698 | CHEBI |
CLM | PDB_CHEM_ID |
CHEMBL130 | ChEMBL_ID |
DB00446 | DRUGBANK_ID |
D002701 | MESH_DESCRIPTOR_UI |
5959 | PUBCHEM_CID |
10901 | IUPHAR_LIGAND_ID |
977 | INN_ID |
66974FR9Q1 | UNII |
2348 | RXNORM |
3887 | MMSL |
4406 | MMSL |
d00025 | MMSL |
002767 | NDDF |
372777009 | SNOMEDCT_US |
57191001 | SNOMEDCT_US |
None